Management of menstrual migraine: A review of current abortive and prophylactic therapies

Current Pain and Headache Reports

Volumn 14, Issue 5, 2010, Pages 376-384

  Sullivan, Elizabeth ^a   Bushnell, Cheryl ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Abortive therapy; Headache; Intermittent prophylaxis; Menstrual migraine; Prophylactic therapy; Triptan

Indexed keywords

ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; FROVATRIPTAN; GESTAGEN; NAPROXEN; NAPROXEN PLUS SUMATRIPTAN; NARATRIPTAN; PLACEBO; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN;

CLINICAL TRIAL; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DYSMENORRHEA; FATIGUE; HEADACHE; HUMAN; MENARCHE; MENSTRUAL CYCLE; MENSTRUAL MIGRAINE; NAUSEA; PARESTHESIA; PREVALENCE; PROPHYLAXIS; REVIEW; UNSPECIFIED SIDE EFFECT;

ANALGESICS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MENSTRUAL CYCLE; MIGRAINE DISORDERS; NAPROXEN; PREMENSTRUAL SYNDROME; TRYPTAMINES;

EID: 77957162502     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-010-0138-2     Document Type: Review

References (40)

1. Scher AI, Stewart WF, Lipton RB: Migraine and headache: a meta-analytic approach. In Epidemiology of Pain. Edited by Crombie IK, Croft PR, Linton SJ, et al. Seattle: IASP Press; 1999:159-170.
2. WF Stewart MS Linet DD Celentano, et al. 1991 Age- and sex-specific incidence rates of migraine with and without visual aura Am J Epidemiol 134 1111 1120 1:STN:280:DyaK38%2FotFOhuw%3D%3D 1746521
3. WF Stewart A Schechter RB Lipton 1994 Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration Neurology 44 6 Suppl 4 S24 S39 1:STN:280:DyaK2c3nslersA%3D%3D 8008223
4. WF Stewart RB Lipton E Chee, et al. 2000 Menstrual cycle and headache in a population sample of migraineurs Neurology 55 1517 1523 1:STN:280: DC%2BD3M%2FmvFKmsg%3D%3D 11094107
5. AJ Dowson SG Kilminster R Salt, et al. 2005 Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: a general practice study Headache 45 274 282 10.1111/j.1526-4610.2005. 05064.x 15836563
6. EA MacGregor A Hackshaw 2004 Prevalence of migraine on each day of the natural menstrual cycle Neurology 63 351 353 15277635
7. F Granella G Sances G Allais, et al. 2004 Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres Cephalalgia 24 707 716 1:STN:280:DC%2BD2cvntlagsA%3D%3D 10.1111/j.1468-2982.2004.00741.x 15315526
8. VT Martin S Wernke K Mandell, et al. 2005 Defining the relationship between ovarian hormones and migraine headache Headache 45 1190 1201 10.1111/j.1526-4610.2005.00242.x 16178949
9. BW Somerville 1972 The role of estradiol withdrawal in the etiology of menstrual migraine Neurology 22 355 365 1:STN:280:DyaE387lsVyltw%3D%3D 5062827
10. BW Somerville 1971 The role of progesterone in menstrual migraine Neurology 21 853 859 1:STN:280:DyaE3M3ptV2quw%3D%3D 5106300
11. VT Martin RB Lipton 2008 Epidemiology and biology of menstrual migraine Headache 48 Suppl 3 S124 S130 10.1111/j.1526-4610.2008.01310.x 19076658
12. C Lokken JE Holm TC Myers 1997 The menstrual cycle and migraine: a time-series analysis of 20 women migraineurs Headache 37 235 239 1:STN:280:DyaK2s3psV2ntA%3D%3D 10.1046/j.1526-4610.1997.3704235.x 9150619
13. JL Brandes 2006 The influence of estrogen on migraine: a systematic review JAMA 295 1824 1830 1:CAS:528:DC%2BD28Xjs12nt7k%3D 10.1001/jama.295.15. 1824 16622144
14. VT Martin 2008 New theories in the pathogenesis of menstrual migraine Curr Pain Headache Rep 12 453 462 10.1007/s11916-008-0077-3 18973740
15. Headache Classification Subcommittee of the International Headache Society 2004 The International Classification of Headache Disorders: 2nd edition Cephalalgia 24 Suppl 1 9 160
16. V Martin R Cady A Mauskop, et al. 2008 Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies Headache 48 226 235 10.1111/j.1526-4610.2008.01310.x 18005144 This well-modeled study evaluated the efficacy of rizatriptan in a subgroup of menstrual migraineurs from the larger TAME study
17. LK Mannix E Loder R Nett, et al. 2007 Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies Cephalalgia 27 414 421 1:STN:280:DC%2BD2s3ktVKnuw%3D%3D 10.1111/j.1468-2982.2007.01313.x 17448179
18. R Nett LK Mannix L Mueller, et al. 2008 Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine Headache 48 1194 1201 10.1111/j.1526-4610.2008.01093.x 18422606
19. LC Newman S Harper BA Jones J Campbell 2009 Frovatriptan for acute treatment of migraine associated with menstruation: Results from an open-label postmarketing surveillance study J Women's Health (Larchmt) 18 1265 1273 10.1089/jwh.2008.1031
20. S Landy N Savani S Shackelford, et al. 2004 Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine Int J Clin Pract 58 913 919 1:CAS:528:DC%2BD2MXkt12isg%3D%3D 10.1111/j.1368-5031.2004.00295.x 15587768
21. R Nett S Landy S Shackelford, et al. 2003 Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine Obstet Gynecol 102 835 842 1:CAS:528:DC%2BD3sXnvVKru70%3D 10.1016/S0029-7844(03)00659-8 14551015
22. LK Mannix VT Martin RK Cady, et al. 2009 Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials Obstet Gynecol 114 106 113 19546766 This randomized, double-blind, multicenter, placebo-controlled trial examines the efficacy of sumatriptan-naproxen in menstrual migraine and connects this with efficacy in dysmenorrhea
23. M Tuchman A Hee U Emeribe S Silberstein 2006 Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine CNS Drugs 20 1019 1026 1:CAS:528:DC%2BD2sXhtlSmt70%3D 10.2165/00023210-200620120-00005 17140280
24. G Allais G Bussone C De Lorenzo, et al. 2007 Naproxen sodium in short-term prophylaxis of pure menstrual migraine: pathophysiological and clinical considerations Neurol Sci 28 Suppl 2 S225 S228 10.1007/s10072-007-0783- 3 17508177
25. V Pfaffenrath 1993 Efficacy and safety of percutaneous estradiol vs placebo in menstrual migraine Cephalalgia 13 Suppl 13 244
26. KD LaGuardia AC Fisher JD Bainbridge, et al. 2005 Suppression of estrogen-withdrawal headache with extended transdermal contraception Fertil Steril 83 1875 1877 10.1016/j.fertnstert.2004.12.048 15950671
27. EA MacGregor A Frith J Ellis, et al. 2006 Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study Neurology 67 2159 2163 1:CAS:528:DC%2BD28XhtlSqurjJ 10.1212/01.wnl.0000249114.52802.55 17190936 This double-blind, placebo-controlled, crossover study evaluates the efficacy of estradiol gel in reduction of menstrual migraine
28. LC Newman RB Lipton CL Lay S Solomon 1998 A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine Neurology 51 307 309 1:CAS:528:DyaK1cXkvVWmt7s%3D 9674831
29. MM Tuchman A Hee U Emeribe S Silberstein 2008 Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study CNS Drugs 22 877 886 1:CAS:528:DC%2BD1cXht1yisbjL 10.2165/00023210- 200822100-00007 18788838 This well-designed study evaluated the efficacy of two dosing regimens of zolmitriptan for intermittent prophylaxis of menstrual migraine
30. L Newman LK Mannix S Landy, et al. 2001 Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study Headache 41 248 256 1:STN:280:DC%2BD3MvotlCktw%3D%3D 10.1046/j.1526-4610.2001.111006248.x 11264684
31. F Moschiano G Allais L Grazzi, et al. 2005 Naratriptan in the short-term prophylaxis of pure menstrual migraine Neurol Sci 26 Suppl 2 S162 S166 10.1007/s10072-005-0435-4 15926020
32. LK Mannix N Savani S Landy, et al. 2007 Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies Headache 47 1037 1049 10.1111/j.1526-4610.2007.00855.x 17635595
33. SD Silberstein AH Elkind C Schreiber C Keywood 2004 A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine Neurology 63 261 269 1:CAS:528:DC%2BD2cXlsV2jt7g%3D 15277618
34. SD Silberstein T Berner J Tobin, et al. 2009 Scheduled short-term prevention with frovatriptan for mi-graine occurring exclusively in association with menstruation Headache 49 1283 1297 10.1111/j.1526-4610.2009.01509.x 19751371
35. JL Brandes A Poole M Kallela, et al. 2009 Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks Cephalalgia 29 1133 1148 1:STN:280:DC%2BD1Mnns1Kmsw%3D%3D 10.1111/j.1468-2982.2009.01840.x 19811503
36. M Guidotti M Mauri C Barrilà, et al. 2007 Frovatriptan vs. transdermal estrogens or naproxen sodium for the prophylaxis of menstrual migraine J Headache Pain 8 283 288 1:CAS:528:DC%2BD1cXitlGktrk%3D 10.1007/s10194-007-0417-4 17955167
37. A Wade S Pawsey H Whale, et al. 2009 Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers Clin Drug Investig 29 325 337 1:CAS:528:DC%2BD1MXmtlait74%3D 10.2165/00044011-200929050-00005 19366274 This very useful study evaluates the pharmacodynamics of frovatriptan and evaluates serum levels with different dosing regimens
38. E Loder P Rizzoli J Golub 2007 Hormonal management of migraine associated with menses and the menopause: A clinical review Headache 47 329 340 10.1111/j.1526-4610.2006.00710.x 17300386 This is an excellent review of current data regarding estrogen and migraine treatment
39. TR Smith J Stoneman 2004 Medication overuse headache from antimigraine therapy: clinical features, pathogenesis and management Drugs 64 2503 2514 1:CAS:528:DC%2BD2MXhs1OmtQ%3D%3D 10.2165/00003495-200464220-00002 15516151
40. EM Perfetto KA Weis CD Mullins, et al. 2005 An economic evaluation of triptan products for migraine Value Health 8 647 655 10.1111/j.1524-4733.2005. 00056.x 16283865